Skip to content

Author

S. Makkawi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

The Efficacy and Safety of Dalfampridine on Cognition and Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Background Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system. People with MS frequently experience cognitive dysfunction and fatigue. Dalfampridine (DAL), a potassium channel blocker, is US Food and Drug Administration-approved for the treatment of walking impairment in people...

Mumen H. Halabi, Rakan S. Alromayan, Maram Almutairi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.